Clinical Services > Pharmacy

9 million Australians take prescription medicines daily

28 August, 2018

More than 9 million people take a prescribed medicine daily, with 8 million taking two or more prescribed medicines a week, according to a new survey.

1 in 5 Australians chemically sensitive

10 July, 2018

Common chemicals are causing many Australians to develop debilitating sensitivities.

MATOS PLUS Pharmacy Refrigerator Range

01 July, 2018

The MATOS PLUS range of refrigerators features an aluminium interior and the latest technology in controllers and compressors for accurate temperature stability.

Some vitamin supplements unhealthy

31 May, 2018

A new study has found that some vitamin and mineral supplements may be detrimental, rather than beneficial, to your health.

From words to action

29 May, 2018 by Kristin Michaels*

In line with international trends, the Advancing of Australian Pharmacy Practice credential provides a pathway to improved outcomes for patients.

BRIVIACT add-on treatment of partial-onset seizures

23 May, 2018

Now available on the PBS, BRIVIACT (brivaracetam) is an add-on therapy for the treatment of partial-onset seizures (POS).

1 in 3 US cardio deaths linked to lead

21 March, 2018

Low-level lead exposure may be responsible for around 30% of premature deaths from cardiovascular disease in the USA each year.

Essential expertise: pharmacists stepping up

27 February, 2018 by Kristin Michaels*

Hospital pharmacists are committed to supporting sustainability.

Fentanyl linked to amnesia

14 February, 2018

Fentanyl — alone, or in combination with stimulants — may put substance users at further risk, whether they take it knowingly or not, by causing amnesia.

Digital pill tracks if patients have ingested their meds

20 November, 2017

The product is approved for the treatment of schizophrenia and bipolar I disorder, as well as for use as an add-on treatment for depression in adults.

Introducing REXULTI® (brexpiprazole): a new PBS-listed antipsychotic for schizophrenia

15 October, 2017

October 1st sees the PBS listing of REXULTI, a novel antipsychotic indicated for the treatment of adults with schizophrenia.

PBS medicines in hospitals — Australia's quiet success story

10 October, 2017 by Kristin Michaels*

The Pharmaceutical Benefit Scheme (PBS) medicines in hospitals program enables hospital access to PBS funding in some capacity in most states and territories. Adoption by NSW and the ACT would cement this landmark program.

Transforming skin cells into a diabetes cure

18 August, 2017

A cure to diabetes is one step closer, with scientists exploring insulin-secreting skin cells.

New date rape drug detection method

17 August, 2017

A urine test may offer more definitive evidence of GHB, supporting law enforcement.

Medical marijuana may not be safe for epilepsy

16 August, 2017

Researchers testing medical marijuana on epilepsy have found it can adversely interact with antiepileptic drugs.

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd